Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cerebrospinal fluid |
PMID[6744640] |
||
NPO549.1 | Musa paradisiaca var. sapientum | Varieties | Musaceae | Eukaryota | TCMID* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[16324927] |
||
NPO2715 | Murraya paniculata | Species | Rutaceae | Eukaryota | TCMID* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[3122251] |
||
NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | TCMID* | |||
NPO18650 | Carassius auratus | Species | Cyprinidae | Eukaryota | HerDing* | |||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO23212 | Vernonia diffusa | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO21795 | Aplysia californica | Species | Aplysiidae | Eukaryota | UNPD* | |||
NPO21500 | Aconitum mokchangense | Species | Ranunculaceae | Eukaryota | UNPD* | |||
NPO8285 | Melicope denhamii | Species | Rutaceae | Eukaryota | UNPD* | |||
NPO19301 | Blatta orientalis | Species | Blattoidae | Eukaryota | UNPD* | |||
NPO22502 | Paraixeris pinnatipartita | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO4017 | Melastoma candidum | Species | Melastomataceae | Eukaryota | UNPD* | |||
NPO23054 | Senecio atratus | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO21734 | Scutellaria woronowii | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO20038 | Acritopappus prunifolius | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO4181 | Pseudoalteromonas luteoviolacea | Species | Pseudoalteromonadaceae | Bacteria | UNPD* | |||
NPO1026 | Pittosporum resiniferum | Species | Pittosporaceae | Eukaryota | UNPD* | |||
NPO23241 | Sigesbeckia orientalis | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO22936 | Myrtillocactus geometrizan | Species | Cactaceae | Eukaryota | UNPD* | |||
NPO29621 | Portulacae herba | NA | NA | NA | TCMSP* | |||
NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | TM-MC* | |||
NPO18650 | Carassius auratus | Species | Cyprinidae | Eukaryota | TCMID* | |||
NPO7191 | Mimosa pudica | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO993 | Phaseolus coccineus | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO29595 | Erinaceus europaeus | Species | Erinaceidae | Eukaryota | TCMID* | |||
NPO3248 | Hemiechinus dauuricus | Species | Erinaceidae | Eukaryota | TCMID* | |||
NPO23714 | Hemiechinus auritus | Species | Erinaceidae | Eukaryota | TCMID* | |||
NPO12323 | Bos taurus | Species | Bovidae | Eukaryota | TCMID* | |||
NPO17393 | Bubalus bubalis | Species | Bovidae | Eukaryota | TCMID* | |||
NPO12181 | Albizia julibrissin | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO11043 | Pisum sativum | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO15859 | Passiflora quadrangularis | Species | Passifloraceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | Ki | = | 281.84 | nM | 8831777 |
NPT3051 | Individual Protein | Alpha-1a adrenergic receptor | Bos taurus | Ki | = | 446.68 | nM | 8831777 |
NPT4554 | Individual Protein | Alpha-1b adrenergic receptor | Mesocricetus auratus | Ki | = | 263.03 | nM | 8831777 |
NPT3048 | Individual Protein | Alpha-1d adrenergic receptor | Rattus norvegicus | Ki | = | 22.39 | nM | 8831777 |
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | EC50 | = | 1174.9 | nM | 8831777 |
NPT1788 | Individual Protein | Alpha-1a adrenergic receptor | Homo sapiens | EC50 | = | 2187.76 | nM | 8831777 |
NPT220 | Individual Protein | Alpha-1b adrenergic receptor | Rattus norvegicus | EC50 | = | 10232.93 | nM | 8831777 |
NPT3048 | Individual Protein | Alpha-1d adrenergic receptor | Rattus norvegicus | EC50 | = | 12.02 | nM | 8831777 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 390 | nM | 2884313 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 37 | nM | 2884313 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | EC50 | = | 83200 | nM | 7562902 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | EC50 | = | 200 | nM | 7562902 |
NPT2 | Others | Unspecified | EC50 | = | 2000 | nM | 7562902 | |
NPT2 | Others | Unspecified | EC50 | = | 12000 | nM | 7562902 | |
NPT2 | Others | Unspecified | EC50 | = | 14500 | nM | 7562902 | |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | EC50 | = | 10000 | nM | 7562902 |
NPT4914 | Individual Protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 30000 | nM | 7562902 |
NPT4915 | Individual Protein | Beta-3 adrenergic receptor | Rattus norvegicus | EC50 | = | 100000 | nM | 7562902 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | EC50 | = | 15800 | nM | 7562902 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | EC50 | = | 1.2 | nM | 7562902 |
NPT2 | Others | Unspecified | EC50 | = | 6.6 | nM | 7562902 | |
NPT2 | Others | Unspecified | EC50 | = | 112 | nM | 7562902 | |
NPT2 | Others | Unspecified | EC50 | = | 30 | nM | 7562902 | |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | EC50 | = | 30 | nM | 7562902 |
NPT4914 | Individual Protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 213 | nM | 7562902 |
NPT4915 | Individual Protein | Beta-3 adrenergic receptor | Rattus norvegicus | EC50 | = | 1580 | nM | 7562902 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 17 | nM | 6296387 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 450 | nM | 8230093 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 4.8 | nM | 8230093 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 126 | nM | 8230093 |
NPT4630 | Individual Protein | Beta-2 adrenergic receptor | Bos taurus | Ki | = | 6000 | nM | 8230093 |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Kd | = | 50000 | nM | 8632409 |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | IC50 | = | 8.00E-05 | nM | 3156993 |
NPT972 | Protein Family | Adrenergic receptor alpha | Rattus norvegicus | IC50 | = | 16 | nM | 7328588 |
NPT970 | Protein Family | Adrenergic receptor alpha-1 | Homo sapiens | Ki | = | 2600 | nM | 8632424 |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | Ki | = | 66 | nM | 8632424 |
NPT3059 | Individual Protein | Alpha-2b adrenergic receptor | Rattus norvegicus | Ki | = | 78 | nM | 8632424 |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | Ki | = | 63 | nM | 8632424 |
NPT1791 | Individual Protein | Nischarin | Homo sapiens | Ki | > | 100000 | nM | 8632424 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 6500 | nM | 10780918 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 30 | nM | 10780918 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 2700 | nM | 10780918 |
NPT4663 | Individual Protein | Beta-2 adrenergic receptor | Canis lupus familiaris | Ki | = | 11000 | nM | 10780918 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Inhibition | = | 18 | % | 10780918 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 340 | nM | 10780918 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 26000 | nM | 10780918 |
NPT4663 | Individual Protein | Beta-2 adrenergic receptor | Canis lupus familiaris | Ki | = | 27000 | nM | 10780918 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 3000 | nM | 10780918 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 20 | nM | 10780918 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 1300 | nM | 10780918 |
NPT4663 | Individual Protein | Beta-2 adrenergic receptor | Canis lupus familiaris | Ki | = | 5000 | nM | 10780918 |
NPT1788 | Individual Protein | Alpha-1a adrenergic receptor | Homo sapiens | Ki | = | 1500 | nM | 2845082 |
NPT971 | Protein Family | Adrenergic receptor alpha-2 | Homo sapiens | Ki | = | 30 | nM | 2845082 |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | Ki | = | 400 | nM | 2845082 |
NPT4913 | Individual Protein | Beta-1 adrenergic receptor | Cavia porcellus | EC50 | = | 350 | nM | 2845082 |
NPT2 | Others | Unspecified | Ratio | = | 50 | 2845082 | ||
NPT2 | Others | Unspecified | EC50 | = | 150 | nM | 6120238 | |
NPT972 | Protein Family | Adrenergic receptor alpha | Rattus norvegicus | IC50 | = | 5000 | nM | 6124637 |
NPT4333 | Protein Family | Adrenergic receptor beta | Rattus norvegicus | IC50 | = | 1000 | nM | 6124637 |
NPT1386 | Protein Family | Adrenergic receptor beta | Homo sapiens | EC50 | = | 2600 | nM | 6124637 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 1000 | nM | 8254623 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 38 | nM | 8254623 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 1600 | nM | 8254623 |
NPT4632 | Individual Protein | Beta-2 adrenergic receptor | Rattus norvegicus | Ki | = | 4200 | nM | 8254623 |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 1500 | nM | 8254623 |
NPT4333 | Protein Family | Adrenergic receptor beta | Rattus norvegicus | EC50 | = | 52 | nM | 8254623 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | = | 1500 | nM | 9767652 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | IC50 | = | 750 | nM | 9767652 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 500 | nM | 7328589 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 390 | nM | 2870187 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | = | 1620 | nM | 2870187 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 37 | nM | 2870187 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | IC50 | = | 33 | nM | 2870187 |
NPT1069 | Individual Protein | Mu opioid receptor | Rattus norvegicus | Ki | = | 14000 | nM | 8064796 |
NPT972 | Protein Family | Adrenergic receptor alpha | Rattus norvegicus | Ratio | = | 1 | 6105214 | |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 450 | nM | 1313109 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 4.8 | nM | 1313109 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 126 | nM | 1313109 |
NPT4630 | Individual Protein | Beta-2 adrenergic receptor | Bos taurus | Ki | = | 6000 | nM | 1313109 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 33 | % | 16302814 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 65 | % | 16302814 |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | EC50 | = | 794.33 | nM | 15566287 |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | EC50 | = | 61.66 | nM | 15566287 |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 371.54 | nM | 15566287 |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 371.54 | nM | 17630725 |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | EC50 | = | 61.66 | nM | 17630725 |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | EC50 | = | 794.33 | nM | 17630725 |
NPT227 | Individual Protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 5.5 | nM | 18083578 |
NPT227 | Individual Protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 6.3 | nM | 18083578 |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 371.54 | nM | 18578476 |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | EC50 | = | 61.66 | nM | 18578476 |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | EC50 | = | 794.33 | nM | 18578476 |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Kd | = | 3980 | nM | 19168263 |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 371.54 | nM | 19886609 |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | EC50 | = | 794.33 | nM | 19886609 |
NPT1789 | Individual Protein | Alpha-1b adrenergic receptor | Homo sapiens | Ki | = | 20400 | nM | 19857969 |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 96700 | nM | 19857969 |
NPT2 | Others | Unspecified | Ki | = | 217000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ki | = | 191000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ki | = | 134000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ki | = | 378000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ki | = | 1776000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ki | = | 342000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ki | = | 490000 | nM | 19857969 | |
NPT2 | Others | Unspecified | Ratio Ki | = | 2.1 | 19857969 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 1.9 | 19857969 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 1.4 | 19857969 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 3.9 | 19857969 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 18.4 | 19857969 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 3.5 | 19857969 | ||
NPT2 | Others | Unspecified | Ratio Ki | = | 5.1 | 19857969 | ||
NPT228 | Individual Protein | Norepinephrine transporter | Homo sapiens | Activity | > | 10000 | % | 19962901 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 33 | % | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 64 | % | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 71 | % | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | IC50 | = | 69 | ug/ml | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | IC50 | > | 100 | ug/ml | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 69 | % | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 102 | % | 20052971 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 123 | % | 20052971 |
NPT2 | Others | Unspecified | Ki | = | 4580 | nM | 16799554 | |
NPT2 | Others | Unspecified | Ki | = | 3310 | nM | 16799554 | |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 11.2 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 2238.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | = | 15848.9 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 794.3 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 7079.5 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 501.2 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 891.3 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 2238.7 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 1258.9 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 56234.1 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 4456.3 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 707.9 | nM | PubChem BioAssay data set |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 110 | nM | 21129985 |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 1995.3 | nM | PubChem BioAssay data set | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | 446.7 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 707.9 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 410.9 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 21192.3 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 6506.4 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 9466.2 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 756.9 | nM | PubChem BioAssay data set | |
NPT534 | Individual Protein | Phosphoglycerate kinase, glycosomal | Trypanosoma brucei brucei | Potency | 37933 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 2590.2 | nM | PubChem BioAssay data set | |
NPT1139 | Individual Protein | Arachidonate 15-lipoxygenase, type II | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 2238.7 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 2119.2 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 6701.6 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 707.9 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 37685.8 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 2058.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14068.4 | nM | PubChem BioAssay data set | ||
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 35338.3 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 118 | nM | 22172308 |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 9074.3 | nM | PubChem BioAssay data set | |
NPT3591 | Individual Protein | Vesicular acetylcholine transporter | Rattus norvegicus | Ki | > | 10000 | nM | 22831799 |
NPT434 | Individual Protein | Solute carrier family 22 member 5 | Mus musculus | Activity | = | 70.9 | % | 11160873 |
NPT1544 | Individual Protein | Solute carrier family 22 member 2 | Rattus norvegicus | IC50 | = | 11000000 | nM | 9830022 |
NPT1542 | Individual Protein | Solute carrier family 22 member 3 | Rattus norvegicus | IC50 | = | 434000 | nM | 9830022 |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 61130.6 | nM | PubChem BioAssay data set | |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 290.9 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT645 | Individual Protein | D-amino-acid oxidase | Homo sapiens | IC50 | > | 10000000 | nM | 23391306 |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Kd | = | 3981.07 | nM | 23954364 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 112.9 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 102.31 | % | 23571415 |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 1901.2 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 611.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 68589.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 611.3 | nM | PubChem BioAssay data set | ||
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | 30131.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 61130.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17228.9 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 891.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 21689.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 33807.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 24336.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | PubChem BioAssay data set | ||
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 1500.3 | nM | PubChem BioAssay data set | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.026 | 10'-6mg/kg | 671451 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 10385 | 671451 | |
NPT2 | Others | Unspecified | FC | = | 100 | 1271416 | ||
NPT1073 | Individual Protein | Dopamine transporter | Rattus norvegicus | FC | = | 100 | 1271416 | |
NPT2 | Others | Unspecified | Activity | = | 0.85 | nM | 191614 | |
NPT2 | Others | Unspecified | Activity | = | 8.84 | nmol | 191614 | |
NPT2 | Others | Unspecified | Activity | = | 0.37 | nM | 191614 | |
NPT2 | Others | Unspecified | Activity | = | 3.85 | nmol | 191614 | |
NPT2 | Others | Unspecified | Activity | = | 1.3 | nM | 191614 | |
NPT2 | Others | Unspecified | Activity | = | 13.52 | nmol | 191614 | |
NPT2 | Others | Unspecified | ED50 | = | 1.1 | nM | 619150 | |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | EC50 | = | 128.82 | nM | 25282262 |
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 19493.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 30637.9 | nM | PubChem BioAssay data set | ||
NPT1788 | Individual Protein | Alpha-1a adrenergic receptor | Homo sapiens | EC50 | = | 9.1 | nM | 26125514 |
NPT2 | Others | Unspecified | EC50 | = | 166 | nM | 27031216 | |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 3300 | nM | 27132867 |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | Ki | = | 1300 | nM | 27132867 |
NPT2 | Others | Unspecified | Ratio Ki | = | 0.39 | 27132867 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC169207 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC115627 |
1.0 | High Similarity | NPC118522 |
0.9412 | High Similarity | NPC236347 |
0.9412 | High Similarity | NPC323775 |
0.9286 | High Similarity | NPC146422 |
0.9106 | High Similarity | NPC326599 |
0.9106 | High Similarity | NPC329595 |
0.9018 | High Similarity | NPC145638 |
0.9018 | High Similarity | NPC290566 |
0.8814 | High Similarity | NPC85276 |
0.8689 | High Similarity | NPC318777 |
0.8571 | High Similarity | NPC137096 |
0.8571 | High Similarity | NPC12278 |
0.8559 | High Similarity | NPC10286 |
0.8559 | High Similarity | NPC213 |
0.8537 | High Similarity | NPC140359 |
0.8537 | High Similarity | NPC13020 |
0.8482 | Intermediate Similarity | NPC68055 |
0.8475 | Intermediate Similarity | NPC142599 |
0.8393 | Intermediate Similarity | NPC110764 |
0.8293 | Intermediate Similarity | NPC284078 |
0.8268 | Intermediate Similarity | NPC145888 |
0.8268 | Intermediate Similarity | NPC161593 |
0.8268 | Intermediate Similarity | NPC16031 |
0.8214 | Intermediate Similarity | NPC125732 |
0.8214 | Intermediate Similarity | NPC131587 |
0.8205 | Intermediate Similarity | NPC71266 |
0.8154 | Intermediate Similarity | NPC88667 |
0.8125 | Intermediate Similarity | NPC109955 |
0.811 | Intermediate Similarity | NPC318965 |
0.8083 | Intermediate Similarity | NPC471485 |
0.8051 | Intermediate Similarity | NPC62258 |
0.8051 | Intermediate Similarity | NPC55617 |
0.8047 | Intermediate Similarity | NPC322366 |
0.8017 | Intermediate Similarity | NPC120280 |
0.7984 | Intermediate Similarity | NPC268572 |
0.7983 | Intermediate Similarity | NPC226401 |
0.7983 | Intermediate Similarity | NPC120982 |
0.7983 | Intermediate Similarity | NPC147634 |
0.7983 | Intermediate Similarity | NPC79793 |
0.7983 | Intermediate Similarity | NPC174096 |
0.7967 | Intermediate Similarity | NPC283468 |
0.7967 | Intermediate Similarity | NPC120075 |
0.7917 | Intermediate Similarity | NPC187583 |
0.7917 | Intermediate Similarity | NPC179002 |
0.7917 | Intermediate Similarity | NPC257430 |
0.7907 | Intermediate Similarity | NPC321561 |
0.7903 | Intermediate Similarity | NPC122009 |
0.7857 | Intermediate Similarity | NPC215351 |
0.7857 | Intermediate Similarity | NPC20142 |
0.7852 | Intermediate Similarity | NPC41473 |
0.7852 | Intermediate Similarity | NPC204848 |
0.7852 | Intermediate Similarity | NPC312770 |
0.7852 | Intermediate Similarity | NPC14600 |
0.7852 | Intermediate Similarity | NPC160607 |
0.7845 | Intermediate Similarity | NPC196479 |
0.784 | Intermediate Similarity | NPC320987 |
0.784 | Intermediate Similarity | NPC181969 |
0.7826 | Intermediate Similarity | NPC29601 |
0.7788 | Intermediate Similarity | NPC107522 |
0.7788 | Intermediate Similarity | NPC313650 |
0.7787 | Intermediate Similarity | NPC264558 |
0.7778 | Intermediate Similarity | NPC120719 |
0.7778 | Intermediate Similarity | NPC35071 |
0.7778 | Intermediate Similarity | NPC177475 |
0.7778 | Intermediate Similarity | NPC148615 |
0.7778 | Intermediate Similarity | NPC471511 |
0.776 | Intermediate Similarity | NPC255675 |
0.776 | Intermediate Similarity | NPC63126 |
0.7744 | Intermediate Similarity | NPC33338 |
0.7744 | Intermediate Similarity | NPC208757 |
0.7744 | Intermediate Similarity | NPC302171 |
0.7744 | Intermediate Similarity | NPC300020 |
0.7742 | Intermediate Similarity | NPC221049 |
0.7712 | Intermediate Similarity | NPC239291 |
0.771 | Intermediate Similarity | NPC153990 |
0.7698 | Intermediate Similarity | NPC477803 |
0.7692 | Intermediate Similarity | NPC477801 |
0.7692 | Intermediate Similarity | NPC477802 |
0.7681 | Intermediate Similarity | NPC66518 |
0.7672 | Intermediate Similarity | NPC223393 |
0.7672 | Intermediate Similarity | NPC130103 |
0.7671 | Intermediate Similarity | NPC37205 |
0.7671 | Intermediate Similarity | NPC160931 |
0.7664 | Intermediate Similarity | NPC299583 |
0.7656 | Intermediate Similarity | NPC266045 |
0.7656 | Intermediate Similarity | NPC470804 |
0.7656 | Intermediate Similarity | NPC476343 |
0.7652 | Intermediate Similarity | NPC271808 |
0.7652 | Intermediate Similarity | NPC164514 |
0.7652 | Intermediate Similarity | NPC108606 |
0.7652 | Intermediate Similarity | NPC290515 |
0.7652 | Intermediate Similarity | NPC226096 |
0.7652 | Intermediate Similarity | NPC474073 |
0.7652 | Intermediate Similarity | NPC303611 |
0.7647 | Intermediate Similarity | NPC477814 |
0.7647 | Intermediate Similarity | NPC19149 |
0.7638 | Intermediate Similarity | NPC472071 |
0.7623 | Intermediate Similarity | NPC280382 |
0.7623 | Intermediate Similarity | NPC268032 |
0.7615 | Intermediate Similarity | NPC105513 |
0.7611 | Intermediate Similarity | NPC138117 |
0.7611 | Intermediate Similarity | NPC325292 |
0.7603 | Intermediate Similarity | NPC473524 |
0.76 | Intermediate Similarity | NPC188867 |
0.76 | Intermediate Similarity | NPC281686 |
0.76 | Intermediate Similarity | NPC106551 |
0.7597 | Intermediate Similarity | NPC209567 |
0.7597 | Intermediate Similarity | NPC298486 |
0.7589 | Intermediate Similarity | NPC300478 |
0.7589 | Intermediate Similarity | NPC300017 |
0.7589 | Intermediate Similarity | NPC312304 |
0.7583 | Intermediate Similarity | NPC176527 |
0.7578 | Intermediate Similarity | NPC470414 |
0.7576 | Intermediate Similarity | NPC477839 |
0.7574 | Intermediate Similarity | NPC64205 |
0.7559 | Intermediate Similarity | NPC135961 |
0.7542 | Intermediate Similarity | NPC178902 |
0.754 | Intermediate Similarity | NPC164386 |
0.7538 | Intermediate Similarity | NPC473451 |
0.7536 | Intermediate Similarity | NPC170170 |
0.7536 | Intermediate Similarity | NPC211468 |
0.7536 | Intermediate Similarity | NPC219233 |
0.7521 | Intermediate Similarity | NPC155847 |
0.7521 | Intermediate Similarity | NPC233835 |
0.7521 | Intermediate Similarity | NPC34864 |
0.7521 | Intermediate Similarity | NPC58427 |
0.7521 | Intermediate Similarity | NPC289381 |
0.7521 | Intermediate Similarity | NPC105727 |
0.7521 | Intermediate Similarity | NPC114392 |
0.75 | Intermediate Similarity | NPC107619 |
0.7483 | Intermediate Similarity | NPC115144 |
0.7483 | Intermediate Similarity | NPC277857 |
0.7482 | Intermediate Similarity | NPC323123 |
0.7481 | Intermediate Similarity | NPC214869 |
0.7481 | Intermediate Similarity | NPC93882 |
0.7481 | Intermediate Similarity | NPC130595 |
0.748 | Intermediate Similarity | NPC8547 |
0.748 | Intermediate Similarity | NPC139617 |
0.748 | Intermediate Similarity | NPC173746 |
0.748 | Intermediate Similarity | NPC156840 |
0.748 | Intermediate Similarity | NPC257124 |
0.748 | Intermediate Similarity | NPC78918 |
0.7479 | Intermediate Similarity | NPC52087 |
0.7479 | Intermediate Similarity | NPC79672 |
0.7459 | Intermediate Similarity | NPC228343 |
0.7459 | Intermediate Similarity | NPC254833 |
0.7458 | Intermediate Similarity | NPC327226 |
0.7444 | Intermediate Similarity | NPC251571 |
0.7444 | Intermediate Similarity | NPC291847 |
0.7442 | Intermediate Similarity | NPC183262 |
0.7426 | Intermediate Similarity | NPC6854 |
0.7426 | Intermediate Similarity | NPC313737 |
0.7426 | Intermediate Similarity | NPC285078 |
0.7424 | Intermediate Similarity | NPC90318 |
0.7422 | Intermediate Similarity | NPC109371 |
0.7422 | Intermediate Similarity | NPC239697 |
0.7422 | Intermediate Similarity | NPC311595 |
0.7422 | Intermediate Similarity | NPC470215 |
0.7422 | Intermediate Similarity | NPC470214 |
0.7422 | Intermediate Similarity | NPC24474 |
0.7422 | Intermediate Similarity | NPC283760 |
0.7417 | Intermediate Similarity | NPC471350 |
0.7411 | Intermediate Similarity | NPC104216 |
0.7407 | Intermediate Similarity | NPC114102 |
0.7405 | Intermediate Similarity | NPC471693 |
0.7405 | Intermediate Similarity | NPC165375 |
0.7405 | Intermediate Similarity | NPC220598 |
0.7405 | Intermediate Similarity | NPC307020 |
0.7402 | Intermediate Similarity | NPC145023 |
0.7402 | Intermediate Similarity | NPC200988 |
0.7402 | Intermediate Similarity | NPC175799 |
0.7402 | Intermediate Similarity | NPC610 |
0.7398 | Intermediate Similarity | NPC222084 |
0.7388 | Intermediate Similarity | NPC155838 |
0.7385 | Intermediate Similarity | NPC322332 |
0.7385 | Intermediate Similarity | NPC211992 |
0.7381 | Intermediate Similarity | NPC4665 |
0.7377 | Intermediate Similarity | NPC153690 |
0.7373 | Intermediate Similarity | NPC174911 |
0.7373 | Intermediate Similarity | NPC294741 |
0.7372 | Intermediate Similarity | NPC218530 |
0.7368 | Intermediate Similarity | NPC58607 |
0.7368 | Intermediate Similarity | NPC178284 |
0.7368 | Intermediate Similarity | NPC191037 |
0.7364 | Intermediate Similarity | NPC265454 |
0.7364 | Intermediate Similarity | NPC252817 |
0.7364 | Intermediate Similarity | NPC34634 |
0.736 | Intermediate Similarity | NPC148969 |
0.736 | Intermediate Similarity | NPC59387 |
0.7355 | Intermediate Similarity | NPC1075 |
0.7355 | Intermediate Similarity | NPC231705 |
0.7355 | Intermediate Similarity | NPC294902 |
0.7355 | Intermediate Similarity | NPC1786 |
0.7348 | Intermediate Similarity | NPC257682 |
0.7348 | Intermediate Similarity | NPC146355 |
0.7348 | Intermediate Similarity | NPC131747 |
0.7344 | Intermediate Similarity | NPC309434 |
0.7344 | Intermediate Similarity | NPC86198 |
0.7339 | Intermediate Similarity | NPC21890 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC169207 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD9384 | Approved |
1.0 | High Similarity | NPD9381 | Approved |
0.9655 | High Similarity | NPD9622 | Approved |
0.9412 | High Similarity | NPD9621 | Approved |
0.9412 | High Similarity | NPD9619 | Approved |
0.9412 | High Similarity | NPD9620 | Approved |
0.9286 | High Similarity | NPD9377 | Approved |
0.9286 | High Similarity | NPD9379 | Approved |
0.9106 | High Similarity | NPD597 | Approved |
0.9106 | High Similarity | NPD598 | Approved |
0.9106 | High Similarity | NPD601 | Approved |
0.9032 | High Similarity | NPD1136 | Approved |
0.9032 | High Similarity | NPD1130 | Approved |
0.9032 | High Similarity | NPD1132 | Approved |
0.9018 | High Similarity | NPD9380 | Clinical (unspecified phase) |
0.896 | High Similarity | NPD3062 | Approved |
0.896 | High Similarity | NPD3061 | Approved |
0.896 | High Similarity | NPD3059 | Approved |
0.8819 | High Similarity | NPD5314 | Approved |
0.8819 | High Similarity | NPD817 | Approved |
0.8819 | High Similarity | NPD823 | Approved |
0.8793 | High Similarity | NPD9614 | Approved |
0.8793 | High Similarity | NPD9618 | Approved |
0.8615 | High Similarity | NPD9570 | Approved |
0.8571 | High Similarity | NPD9615 | Approved |
0.8571 | High Similarity | NPD9613 | Approved |
0.8571 | High Similarity | NPD9616 | Approved |
0.85 | High Similarity | NPD316 | Approved |
0.8417 | Intermediate Similarity | NPD318 | Approved |
0.8417 | Intermediate Similarity | NPD317 | Approved |
0.8417 | Intermediate Similarity | NPD856 | Approved |
0.8417 | Intermediate Similarity | NPD16 | Approved |
0.8409 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.832 | Intermediate Similarity | NPD9634 | Clinical (unspecified phase) |
0.832 | Intermediate Similarity | NPD5311 | Approved |
0.832 | Intermediate Similarity | NPD5310 | Approved |
0.8268 | Intermediate Similarity | NPD9569 | Approved |
0.8254 | Intermediate Similarity | NPD3055 | Approved |
0.8254 | Intermediate Similarity | NPD3053 | Approved |
0.8168 | Intermediate Similarity | NPD555 | Phase 2 |
0.8154 | Intermediate Similarity | NPD259 | Phase 1 |
0.8087 | Intermediate Similarity | NPD9608 | Approved |
0.8087 | Intermediate Similarity | NPD9610 | Approved |
0.8047 | Intermediate Similarity | NPD599 | Approved |
0.8047 | Intermediate Similarity | NPD859 | Approved |
0.8047 | Intermediate Similarity | NPD602 | Approved |
0.8047 | Intermediate Similarity | NPD858 | Approved |
0.8016 | Intermediate Similarity | NPD2561 | Approved |
0.8016 | Intermediate Similarity | NPD2562 | Approved |
0.8015 | Intermediate Similarity | NPD3060 | Approved |
0.8 | Intermediate Similarity | NPD9536 | Phase 1 |
0.8 | Intermediate Similarity | NPD9537 | Phase 1 |
0.7986 | Intermediate Similarity | NPD4160 | Clinical (unspecified phase) |
0.797 | Intermediate Similarity | NPD2568 | Approved |
0.7939 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.7907 | Intermediate Similarity | NPD258 | Approved |
0.7907 | Intermediate Similarity | NPD257 | Approved |
0.7899 | Intermediate Similarity | NPD302 | Approved |
0.7833 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.7829 | Intermediate Similarity | NPD1135 | Approved |
0.7829 | Intermediate Similarity | NPD1134 | Approved |
0.7829 | Intermediate Similarity | NPD1133 | Approved |
0.7829 | Intermediate Similarity | NPD1131 | Approved |
0.7829 | Intermediate Similarity | NPD1129 | Approved |
0.782 | Intermediate Similarity | NPD825 | Approved |
0.782 | Intermediate Similarity | NPD826 | Approved |
0.7671 | Intermediate Similarity | NPD2978 | Approved |
0.7671 | Intermediate Similarity | NPD2977 | Approved |
0.7652 | Intermediate Similarity | NPD9611 | Approved |
0.7652 | Intermediate Similarity | NPD9609 | Approved |
0.7652 | Intermediate Similarity | NPD600 | Approved |
0.7652 | Intermediate Similarity | NPD596 | Approved |
0.7652 | Intermediate Similarity | NPD9612 | Approved |
0.7634 | Intermediate Similarity | NPD558 | Phase 2 |
0.7612 | Intermediate Similarity | NPD6407 | Approved |
0.7612 | Intermediate Similarity | NPD6405 | Approved |
0.76 | Intermediate Similarity | NPD9568 | Approved |
0.7597 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7597 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7569 | Intermediate Similarity | NPD3687 | Approved |
0.7569 | Intermediate Similarity | NPD3686 | Approved |
0.7536 | Intermediate Similarity | NPD1632 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD275 | Approved |
0.75 | Intermediate Similarity | NPD4162 | Approved |
0.75 | Intermediate Similarity | NPD274 | Approved |
0.7483 | Intermediate Similarity | NPD3645 | Discontinued |
0.7481 | Intermediate Similarity | NPD829 | Discontinued |
0.7481 | Intermediate Similarity | NPD2674 | Phase 3 |
0.748 | Intermediate Similarity | NPD228 | Approved |
0.7462 | Intermediate Similarity | NPD2337 | Clinical (unspecified phase) |
0.7459 | Intermediate Similarity | NPD3022 | Approved |
0.7459 | Intermediate Similarity | NPD3021 | Approved |
0.7405 | Intermediate Similarity | NPD4659 | Approved |
0.7397 | Intermediate Similarity | NPD3455 | Phase 2 |
0.7364 | Intermediate Similarity | NPD5238 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD1445 | Approved |
0.7355 | Intermediate Similarity | NPD1444 | Approved |
0.7353 | Intermediate Similarity | NPD840 | Approved |
0.7353 | Intermediate Similarity | NPD839 | Approved |
0.7333 | Intermediate Similarity | NPD314 | Approved |
0.7333 | Intermediate Similarity | NPD311 | Approved |
0.7333 | Intermediate Similarity | NPD310 | Approved |
0.7333 | Intermediate Similarity | NPD309 | Approved |
0.7333 | Intermediate Similarity | NPD315 | Approved |
0.7333 | Intermediate Similarity | NPD10 | Approved |
0.7319 | Intermediate Similarity | NPD3052 | Approved |
0.7319 | Intermediate Similarity | NPD3054 | Approved |
0.7305 | Intermediate Similarity | NPD7153 | Discontinued |
0.7293 | Intermediate Similarity | NPD4103 | Phase 2 |
0.7293 | Intermediate Similarity | NPD4104 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD3144 | Approved |
0.7279 | Intermediate Similarity | NPD3145 | Approved |
0.7273 | Intermediate Similarity | NPD5137 | Approved |
0.7266 | Intermediate Similarity | NPD3554 | Approved |
0.7266 | Intermediate Similarity | NPD3552 | Approved |
0.7266 | Intermediate Similarity | NPD3553 | Approved |
0.7266 | Intermediate Similarity | NPD3555 | Approved |
0.7244 | Intermediate Similarity | NPD256 | Approved |
0.7244 | Intermediate Similarity | NPD255 | Approved |
0.7239 | Intermediate Similarity | NPD2195 | Approved |
0.7239 | Intermediate Similarity | NPD2194 | Approved |
0.7222 | Intermediate Similarity | NPD2229 | Approved |
0.7222 | Intermediate Similarity | NPD2228 | Approved |
0.7222 | Intermediate Similarity | NPD2422 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD3845 | Phase 1 |
0.7222 | Intermediate Similarity | NPD2234 | Approved |
0.7206 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7206 | Intermediate Similarity | NPD3136 | Phase 2 |
0.7192 | Intermediate Similarity | NPD7527 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD52 | Approved |
0.7192 | Intermediate Similarity | NPD7526 | Approved |
0.7177 | Intermediate Similarity | NPD1792 | Phase 2 |
0.7165 | Intermediate Similarity | NPD1793 | Approved |
0.7165 | Intermediate Similarity | NPD1791 | Approved |
0.7133 | Intermediate Similarity | NPD3638 | Discontinued |
0.7121 | Intermediate Similarity | NPD5350 | Clinical (unspecified phase) |
0.7121 | Intermediate Similarity | NPD5351 | Clinical (unspecified phase) |
0.7113 | Intermediate Similarity | NPD1375 | Discontinued |
0.7101 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD1242 | Phase 1 |
0.705 | Intermediate Similarity | NPD1613 | Approved |
0.705 | Intermediate Similarity | NPD2238 | Phase 2 |
0.705 | Intermediate Similarity | NPD1558 | Phase 1 |
0.705 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD1819 | Approved |
0.7037 | Intermediate Similarity | NPD1817 | Approved |
0.7037 | Intermediate Similarity | NPD1818 | Approved |
0.7037 | Intermediate Similarity | NPD1820 | Approved |
0.7034 | Intermediate Similarity | NPD2677 | Approved |
0.7034 | Intermediate Similarity | NPD5241 | Discontinued |
0.7023 | Intermediate Similarity | NPD4093 | Discontinued |
0.7014 | Intermediate Similarity | NPD4237 | Approved |
0.7014 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7007 | Intermediate Similarity | NPD3536 | Discontinued |
0.6993 | Remote Similarity | NPD7978 | Discontinued |
0.6985 | Remote Similarity | NPD7451 | Discontinued |
0.698 | Remote Similarity | NPD1973 | Approved |
0.698 | Remote Similarity | NPD1969 | Clinical (unspecified phase) |
0.698 | Remote Similarity | NPD1972 | Approved |
0.6972 | Remote Similarity | NPD1753 | Discontinued |
0.6963 | Remote Similarity | NPD196 | Phase 1 |
0.6959 | Remote Similarity | NPD5261 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD3179 | Approved |
0.6957 | Remote Similarity | NPD3180 | Approved |
0.6949 | Remote Similarity | NPD2934 | Approved |
0.6949 | Remote Similarity | NPD1432 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD2933 | Approved |
0.6942 | Remote Similarity | NPD289 | Clinical (unspecified phase) |
0.6939 | Remote Similarity | NPD1774 | Approved |
0.6923 | Remote Similarity | NPD2161 | Phase 2 |
0.6917 | Remote Similarity | NPD2688 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD3056 | Clinical (unspecified phase) |
0.6903 | Remote Similarity | NPD111 | Approved |
0.6892 | Remote Similarity | NPD3157 | Approved |
0.6892 | Remote Similarity | NPD3158 | Phase 1 |
0.6892 | Remote Similarity | NPD4123 | Phase 3 |
0.6891 | Remote Similarity | NPD844 | Approved |
0.6891 | Remote Similarity | NPD2859 | Approved |
0.6891 | Remote Similarity | NPD2860 | Approved |
0.6885 | Remote Similarity | NPD855 | Approved |
0.6885 | Remote Similarity | NPD854 | Approved |
0.6885 | Remote Similarity | NPD940 | Approved |
0.6885 | Remote Similarity | NPD846 | Approved |
0.6884 | Remote Similarity | NPD5752 | Clinical (unspecified phase) |
0.6866 | Remote Similarity | NPD3092 | Approved |
0.6863 | Remote Similarity | NPD5773 | Approved |
0.6863 | Remote Similarity | NPD6818 | Clinical (unspecified phase) |
0.6863 | Remote Similarity | NPD5772 | Approved |
0.686 | Remote Similarity | NPD3020 | Approved |
0.6857 | Remote Similarity | NPD1423 | Approved |
0.6842 | Remote Similarity | NPD1751 | Approved |
0.6835 | Remote Similarity | NPD3166 | Approved |
0.6835 | Remote Similarity | NPD3164 | Approved |
0.6835 | Remote Similarity | NPD3167 | Approved |
0.6835 | Remote Similarity | NPD3165 | Approved |
0.6833 | Remote Similarity | NPD288 | Approved |
0.6831 | Remote Similarity | NPD2653 | Approved |
0.6818 | Remote Similarity | NPD2226 | Clinical (unspecified phase) |
0.6788 | Remote Similarity | NPD1794 | Approved |
0.6788 | Remote Similarity | NPD3094 | Phase 2 |
PubChem CID   | 439260 |
ChEMBL   | CHEMBL1437 |
ZINC   |
Molecular Weight:   | 169.07 |
ALogP:   | -2.1696 |
MLogP:   | 1.9 |
XLogP:   | -0.46 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 86.71 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 4 |
# Rings:   | 1 |
# Heavy Atoms:   | 12 |